Bonus3 Sept 2026, 12:14 pm
Titan Biotech Recommends 1:4 Bonus Share Issue
AI Summary
Titan Biotech Ltd's Board of Directors has approved the issuance of bonus shares in a 1:4 ratio, subject to shareholder approval. The company also proposed an increase in authorized share capital from ₹10 crore to ₹10.40 crore to facilitate this bonus issue. Additionally, the Board recommended the re-appointment of Mr. Rohit Jain as an Independent Director for a second five-year term. The 34th Annual General Meeting is scheduled for September 29, 2026, with September 22, 2026, set as the cut-off date for voting eligibility and record date for a final dividend of ₹0.50 per share. Book closure is from September 23 to September 29, 2026.
Key Highlights
- Board approves 1:4 bonus share issuance, pending shareholder nod.
- Authorized share capital to increase from ₹10 Cr to ₹10.40 Cr.
- Re-appointment of Independent Director Rohit Jain recommended.
- AGM scheduled for Sep 29, 2026; dividend of ₹0.50 per share proposed.
- Record date for dividend and AGM eligibility is Sep 22, 2026.
Price Impact
More from TITANBIO